GRATICULE
LIVE

Serial Number

98253910

Owner

Graticule, Inc.

Attorney

Perry Gattegno

First Use Date

Oct 3, 2018

Filing Date

Nov 3, 2023

Add to watchlist:

No watchlists yet
View on USPTO

GRATICULE Trademark

Serial Number: 98253910 • Registration: 7528486

GRATICULE is a trademark filed by Graticule, Inc. on November 3, 2023. The trademark is classified under Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Graticule, Inc. (4 trademarks)

199 Pleasant St
Newton, MA 02459

Entity Type: 03

Trademark Details

Filing Date

November 3, 2023

Registration Date

October 8, 2024

First Use Anywhere

October 3, 2018

First Use in Commerce

October 3, 2018

Published for Opposition

July 23, 2024

Goods & Services

Business consulting services; Consulting services in the field of patient relationship management for healthcare providers; Data processing services in the field of healthcare, namely, curation, de-identification, and enrichment of healthcare, medical, clinical, and patient data; Recruitment and placement of volunteers in the field of clinical studies, namely, recruiting and placing patients for participation in clinical studies for the testing of drugs, testing of medical devices, and diagnostic research; Business data analysis services in the field of healthcare, medical, clinical, and patient data; Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; Collecting and analyzing claims data from healthcare organizations for business purposes; Commercial administration of the licensing of healthcare, biotechnology, and clinical data of others; Providing consulting services in the field of regulatory submission management to medical companies to assist them with applications for medical device approval; Recruitment advertisement services, namely, posting of clinical trial notices for the purpose of recruiting patients for participation in clinical trials for the testing of drugs

Consulting services in the field of healthcare; Health care services, namely, providing a database featuring information in the field of health, in particular, patient information in the field of neurology, cardiology, oncology and rare diseases information and featuring inputting and collection of data and information all for treatment and diagnostic purposes; Remote monitoring of medical data for medical diagnosis and treatment

Innovation consulting services, namely, advising others in the areas of product development; Platform as a service (PAAS) featuring computer software platforms for life science research and development, comparative effectiveness studies, medical device safety surveillance, patient identification, clinical trial recruitment, leveraging advanced data sets, quality of life reimbursement justification, synthetic control arms, rare disease detection, and automated population of electronic data capture systems; Platform as a service (PAAS) featuring computer software platforms for regulatory-grade real world clinical and patient data to accelerate biotechnology, medical device, and diagnostic research; Platform as a service (PAAS) featuring computer software platforms for providing access to an electronic exchange of medical records across a nationwide health information network; Software as a service (SAAS) services featuring software for life science research and development, comparative effectiveness studies, medical device safety surveillance, patient identification, clinical trial recruitment, leveraging advanced data sets, quality of life reimbursement justification, synthetic control arms, rare disease detection, and automated population of electronic data capture systems; Software as a service (SAAS) services featuring software for regulatory-grade real world clinical and patient data to accelerate biotechnology, medical device, and diagnostic research; Software as a service (SAAS) services featuring software for providing access to an electronic exchange of medical records across a nationwide health information network; Compiling data for research purposes in the field of medical science and medical consultancy; Providing an on-line searchable database in the field of healthcare data, biotechnology data as it relates to healthcare, medical data, clinical data, and patient data, all for scientific research purposes

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Oct 8, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Oct 8, 2024 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 23, 2024 NPUB
PUBLISHED FOR OPPOSITION
Jul 23, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 3, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 18, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Jun 18, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jun 18, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Jun 18, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jun 18, 2024 CNEA
EXAMINER'S AMENDMENT ENTERED
Jun 18, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jun 18, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Jun 18, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jun 18, 2024 CNEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 17, 2024 GNRN
NON-FINAL ACTION E-MAILED
Jun 17, 2024 GNRT
NON-FINAL ACTION WRITTEN
Jun 17, 2024 CNRT
ASSIGNED TO EXAMINER
Jun 13, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 22, 2024 NWOS
NEW APPLICATION ENTERED
Nov 3, 2023 NWAP